Skip to Content
Header image

Live Webinar – Your Regulatory CMC Roadmap: Clinical Development Considerations for Small Molecules and Recombinant Proteins 

Thu, Aug 1st 2024 - Thu, Aug 1st 2024, 12:00 pm - 1:00 am
Virtual

Join our Regulatory CMC team for a live webinar on Thursday, August 1 at Noon EST to discuss Your Regulatory CMC Roadmap: Clinical Development Considerations for Small Molecules and Recombinant Proteins. They will walk you through critical questions and provide examples and scenarios, highlighting your successful Regulatory CMC roadmap across the clinical development lifecycle.

Register here!

The differences in Chemistry, Manufacturing, and Controls (CMC) and Regulatory CMC expertise are vast. When biotechnology and pharmaceutical companies do not have internal Regulatory CMC expertise, key considerations can be missed throughout their product’s development lifecycle. Often, companies hold assets across a broad range of modalities, including both small molecules and recombinant proteins, which requires a nuanced understanding of the requirements and considerations for each product type. 

Perhaps you’ve been asking the following questions: 

Speakers: 

More Details